| Sanford Pharmacy Moorhead | |
| 4000 28th S Ave, Moorhead, Minnesota 56560 | |
| (701) 234-3250 |
| Name | Sanford Pharmacy Moorhead |
|---|---|
| Organization Name | Sanford Clinic North |
| Location | 4000 28th S Ave, Moorhead, Minnesota 56560 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (701) 234-3250 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.
About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A large study has found that removal of the tonsils as a child can mean that the individual is more susceptible to chest infections as an adult. The study appeared in the latest issue of the journal JAMA Otolaryngology Head and Neck Surgery.
› Verified 5 days ago
| NPI Number | 1124122783 |
| Organization Name | SANFORD MEDICAL CENTER FARGO |
| Doing Business As | SANFORD PHARMACY MOORHEAD |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4000 28th Ave S, Moorhead, MN 56560 |
| Phone Number | 701-234-3250 |
News Archive
The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.
About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A large study has found that removal of the tonsils as a child can mean that the individual is more susceptible to chest infections as an adult. The study appeared in the latest issue of the journal JAMA Otolaryngology Head and Neck Surgery.
› Verified 5 days ago
| NPI Number | 1780287300 |
| Organization Name | SANFORD CLINIC NORTH |
| Type | Pharmacy |
| Address | 4000 28th S Ave, Moorhead, MN 56560 |
| Phone Number | 701-234-3250 |
News Archive
The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.
About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A large study has found that removal of the tonsils as a child can mean that the individual is more susceptible to chest infections as an adult. The study appeared in the latest issue of the journal JAMA Otolaryngology Head and Neck Surgery.
› Verified 5 days ago
News Archive
The ability for cancer cells to develop resistance to chemotherapy drugs - known as multi-drug resistance - remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to "turn off" their resistance capabilities.
About nine out of 10 new cancer drugs successfully clear preclinical development hurdles, but then they fail in human clinical testing. A new partnership facilitated by SAIC-Frederick Inc. aims to help change that outcome.
Syndax Pharmaceuticals, Inc. announced today that data from ENGAGE 501, a multicenter, phase 2 study, demonstrated entinostat, a novel, oral small molecule inhibitor of class I histone deacetylases, showed activity as a single agent in patients with relapsed or refractory Hodgkin's lymphoma.
A large study has found that removal of the tonsils as a child can mean that the individual is more susceptible to chest infections as an adult. The study appeared in the latest issue of the journal JAMA Otolaryngology Head and Neck Surgery.
› Verified 5 days ago
Cvs Pharmacy #08527 Type: Medicare Supplier Location: 822 30th Ave S, Moorhead, Minnesota 56560 Phone: (218) 236-0807 | |
Cvs Pharmacy #16185 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3301 Highway 10 E, Moorhead, Minnesota 56560 Phone: (218) 233-2953 | |
Sanford Pharmacy Moorhead Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4000 28th S Ave, Moorhead, Minnesota 56560 Phone: (701) 234-3250 | |
Walgreens #10187 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 900 Main Ave, Moorhead, Minnesota 56560 Phone: (218) 236-0252 | |
Cash Wise Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3300 Highway 10 E, Moorhead, Minnesota 56560 Phone: (218) 236-0345 |